$141 Million is the total value of FARLEY CAPITAL L.P.'s 17 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was 18.8% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
VRX | Sell | VALEANT PHARMACEUTICALS INTL | $37,626,000 | -16.0% | 262,920 | -23.0% | 26.64% | -11.5% |
DV | Sell | DEVRY ED GROUP INC | $27,436,000 | -13.4% | 577,975 | -21.9% | 19.43% | -8.8% |
MA | Sell | MASTERCARD INCcl a | $20,373,000 | +13.3% | 236,452 | -2.8% | 14.43% | +19.4% |
GOOG | Buy | GOOGLE INCcl c | $14,928,000 | -8.8% | 28,359 | +0.1% | 10.57% | -3.9% |
GOOGL | GOOGLE INCcl a | $11,411,000 | -9.8% | 21,504 | 0.0% | 8.08% | -5.0% | |
MON | Sell | MONSANTO CO | $11,312,000 | -26.1% | 94,681 | -30.4% | 8.01% | -22.1% |
NSR | Sell | NEUSTAR INCcl a | $6,385,000 | +6.6% | 229,665 | -4.8% | 4.52% | +12.3% |
J | Buy | JACOBS ENGR GROUP INC DEL | $5,077,000 | +1056.5% | 113,599 | +1320.0% | 3.60% | +1118.6% |
LXFT | New | LUXOFT HLDG INC | $2,881,000 | – | 74,804 | +100.0% | 2.04% | – |
VALEANT PHARMACEUTICALS INTL | $1,431,000 | +9.1% | 10,000 | 0.0% | 1.01% | +14.9% | ||
V | VISA | $629,000 | +22.9% | 2,400 | 0.0% | 0.44% | +29.4% | |
NSC | NORFOLK SOUTHERN CORP | $404,000 | -1.9% | 3,690 | 0.0% | 0.29% | +3.2% | |
BRKB | BERKSHIRE HATHAWAY INC DELcl b | $386,000 | +8.7% | 2,570 | 0.0% | 0.27% | +14.2% | |
SYMC | SYMANTEC CORP | $308,000 | +9.6% | 12,000 | 0.0% | 0.22% | +15.3% | |
XOM | Sell | EXXON MOBIL CORP | $251,000 | -8.4% | 2,710 | -6.9% | 0.18% | -3.3% |
BRKA | BERKSHIRE HATHAWAY INC DELcl a | $226,000 | +9.2% | 1 | 0.0% | 0.16% | +15.1% | |
PBHC | New | PATHFINDER BANCORP INC MD | $153,000 | – | 15,608 | +100.0% | 0.11% | – |
LUK | Exit | LEUCADIA NATIONAL CORPORATION | $0 | – | -9,362 | -100.0% | -0.15% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-02-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MASTERCARD INC | 35 | Q3 2023 | 43.3% |
BERKSHIRE HATHAWAY INC DEL | 35 | Q3 2023 | 2.6% |
BERKSHIRE HATHAWAY INC DEL | 28 | Q3 2023 | 0.6% |
ALPHABET INC | 25 | Q3 2023 | 20.9% |
ALPHABET INC | 25 | Q3 2023 | 1.4% |
ADTALEM GLOBAL ED INC | 19 | Q3 2023 | 56.8% |
VALEANT PHARMACEUTICALS INTL | 19 | Q4 2017 | 30.1% |
DEVRY INC DEL | 16 | Q1 2017 | 58.4% |
META PLATFORMS INC | 16 | Q3 2023 | 11.7% |
PRAXAIR INC | 13 | Q4 2017 | 3.6% |
View FARLEY CAPITAL L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
LaPorte Bancorp, Inc. | February 14, 2014 | ? | ? |
Oconee Federal Financial Corp. | February 14, 2014 | ? | ? |
Sunshine Financial Inc | February 14, 2014 | ? | ? |
BSB Bancorp, Inc.Sold out | February 14, 2013 | 0 | 0.0% |
IF Bancorp, Inc.Sold out | February 14, 2013 | 0 | 0.0% |
Jacksonville Bancorp, Inc.Sold out | February 14, 2013 | 0 | 0.0% |
Poage Bankshares, Inc.Sold out | February 14, 2013 | 0 | 0.0% |
SP Bancorp, Inc.Sold out | February 14, 2013 | 0 | 0.0% |
West End Indiana Bancshares, Inc.Sold out | February 14, 2013 | 0 | 0.0% |
OBA Financial Services, Inc.Sold out | February 14, 2012 | 0 | 0.0% |
View FARLEY CAPITAL L.P.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-08 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-11 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View FARLEY CAPITAL L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.